251 filings
Page 2 of 13
8-K
c0oaap6b3ce
23 Oct 23
Amendments to Articles of Incorporation or Bylaws
4:44pm
8-K
tfevkbaq3ng y3jw70
25 Sep 23
Changes in Registrant's Certifying Accountant
4:20pm
8-K
19b9l3v cjattdk0v
8 Sep 23
Regulation FD Disclosure
4:20pm
8-K
8tc1w6dowxigq6nv
1 Sep 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:17pm
8-K/A
xm7qedgqsay3xgzuh
21 Aug 23
Changes in Registrant's Certifying Accountant
5:13pm
NT 10-Q
edrjw
15 Aug 23
Notice of late quarterly filing
8:30am
424B5
wwgo4o buuwgiybrp
20 Jul 23
Prospectus supplement for primary offering
4:07pm
8-K
h7e1fuwj
19 Jul 23
Genprex Announces $7.5 Million Registered Direct Offering PricedĀ At-the-MarketĀ Under Nasdaq Rules
4:06pm
8-K
tkb0qc
18 Jul 23
Genprex Signs Exclusive License to Additional Diabetes Technology with the University of Pittsburgh
9:06am
8-K
u7o3itet
14 Jul 23
Changes in Registrant's Certifying Accountant
4:32pm
8-K
k7zn68wzxql586xu6
27 Jun 23
Submission of Matters to a Vote of Security Holders
4:28pm
EFFECT
eys2b3z328sl
12 Jun 23
Notice of effectiveness
12:15am
CORRESP
6d8ubyw2lvq
7 Jun 23
Correspondence with SEC
12:00am
8-K
dlfbcyya7apphufja1
26 May 23
Other Events
4:42pm
NT 10-Q
oqy4mhw6c3lxyu
16 May 23
Notice of late quarterly filing
8:35am
8-K/A
hbox bk21xlf
12 May 23
Changes in Registrant's Certifying Accountant
4:05pm
ARS
wc3jxex00ljzjh
28 Apr 23
Annual report to shareholders
8:32am
DEFA14A
u341a30 5ent9
28 Apr 23
Additional proxy soliciting materials
8:16am